AGEN Overview
Upcoming Projects (AGEN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AGEN)
-
Discussing botensilimab, a next-gen CTLA4 from Agenus, in combination with an anti-PD-1 in metastatic colorectal cancer (CRC)
Ticker: AGEN
Executed On: Jul 07, 2023 at 08:00 AM EDT
Upcoming & Overdue Catalysts (AGEN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AGEN)
-
Agenus (AGEN) Doses First Patient in Phase 1/2 Study Evaluating AGEN2034 in Advanced Tumors and Cervical Cancer
Ticker: AGEN
Occurred on: Apr 20, 2017 -
Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-GITR Checkpoint Antibody INCAGN1876 in Patients with Solid Tumors
Ticker: AGEN
Occurred on: Jun 22, 2016
Strategic Initiatives (AGEN)
-
Incyte (INCY) and Agenus (AGEN) Announce Amended Collaboration Agreement
Tickers: AGEN, INCY
Announcement Date: Feb 14, 2017 -
Agenus Announces Lead Product Candidate Selection in its Collaboration with Merck
Tickers: AGEN, MRK
Announcement Date: Jun 09, 2016
